Literature DB >> 11791590

Intestinal metaplasia of the esophagus or esophagogastric junction: evidence of distinct clinical, pathologic, and histochemical staining features.

Johanna W van Sandick1, Jan B van Lanschot, Lonneke van Felius, Jelle Haringsma, Guido N J Tytgat, Wim Dekker, Paul Drillenburg, G Johan A Offerhaus, Fiebo J W ten Kate.   

Abstract

Our purpose was to evaluate the clinical, histologic, and histochemical staining characteristics of intestinal metaplasia (IM) at an endoscopically normal-appearing esophagogastric junction (IM-EGJ) compared with IM in a columnar-lined esophagus (IM-CLE). A prospective study included 253 patients referred for elective upper gastrointestinal endoscopy. Biopsy specimens were obtained from 2 cm above and immediately distal to the squamocolumnar junction, the gastric corpus, and the antrum. Any red mucosa above the EGJ was sampled. IM-CLE (prevalence, 5.5%) typically occurred in white male smokers with a long history of reflux symptoms. IM-EGJ (prevalence, 9.1%) was associated with corpus and antrum gastritis and with IM at these sites. IM-CLE usually (13/14 [93%]) was the incomplete type IM, whereas only 12 (52%) of 23 patients in the IM-EGJ group had incomplete IM. IM-EGJ and IM-CLE should be considered as separate entities. Further research is needed to evaluate whether neoplastic progression of IM-EGJ is related to its mucin profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11791590     DOI: 10.1309/N15U-FN5R-3M5D-PE0U

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  Report of an Amsterdam working group on Barrett esophagus.

Authors:  G J A Offerhaus; P Correa; S van Eeden; K Geboes; P Drillenburg; M Vieth; M L van Velthuysen; H Watanabe; P Sipponen; F J W ten Kate; F T Bosman; A Bosma; A Ristimaki; H van Dekken; R Riddell; G N J Tytgat
Journal:  Virchows Arch       Date:  2003-09-27       Impact factor: 4.064

Review 2.  [Barrett's esophagus. An update].

Authors:  G B Baretton; D E Aust
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

Review 3.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  Human defensin 5 expression in intestinal metaplasia of the upper gastrointestinal tract.

Authors:  B Shen; E M Porter; E Reynoso; C Shen; D Ghosh; J T Connor; J Drazba; H K Rho; T L Gramlich; R Li; A H Ormsby; M-S Sy; T Ganz; C L Bevins
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

Review 5.  Barrett's esophagus and Barrett's carcinoma.

Authors:  Burkhard H A von Rahden; Hubert J Stein; Jörg R Siewert
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

6.  Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.

Authors:  C J Buskens; A Sivula; B P van Rees; C Haglund; G J A Offerhaus; J J B van Lanschot; A Ristimäki
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

7.  The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?

Authors:  A Meining; R Ott; I Becker; S Hahn; J Mühlen; M Werner; H Höfler; M Classen; W Heldwein; T Rösch
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 8.  Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China.

Authors:  Li-Dong Wang; Shu Zheng; Zuo-Yu Zheng; Alan G Casson
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.